Effect of liraglutide on cardiovascular outcomes in patients with or without prior heart failure history in LEADER

被引：0
|
作者：
Saevereid, H. A. [1 ]
Husain, M. [2 ]
Bain, S. C. [3 ]
Mann, J. F. E. [4 ]
Nauck, M. A. [5 ]
Poulter, N. [6 ]
Goldman, B. [1 ]
Thomsen, A. B. [1 ]
Marso, S. [7 ]
机构：
[1] Novo Nordisk AS, Soborg, Denmark
[2] Toronto Gen Hosp, Res Inst, Ted Rogers Ctr Heart Res, Toronto, ON, Canada
[3] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales
[4] Friedrich Alexander Univ Erlangen, Erlangen, Germany
[5] Ruhr Univ Bochum, St Josef Hosp, Diabet Ctr Bochum Hattingen, Bochum, Germany
[6] Imperial Coll London, London, England
[7] HCA Midwest Hlth Heart & Vasc Inst, Kansas City, MO USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1155
引用
收藏
页码：S564 / S565
页数：2
相关论文
共 50 条
  • [21] Paracetamol and adverse cardiovascular outcomes in patients with heart failure
    Ren, Q. W.
    Zhang, J. N.
    Guo, R. A. N.
    Gu, W. L.
    Yiu, K. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [22] Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)
    Meier, J. J.
    Nitschmann, S.
    INTERNIST, 2017, 58 (03): : 303 - 305
  • [23] THE RISK AND PREDICATORS OF DIASTOLIC HEART FAILURE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS WITHOUT PRIOR CARDIOVASCULAR DISEASE
    Haddadin, Suhail
    Haddadin, Farah
    Mdanat, Eyadeh
    Aleyadeh, Wesam
    Gelman, Bruce
    GASTROENTEROLOGY, 2023, 164 (06) : S1296 - S1296
  • [24] Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction
    Malik, Awais
    Gill, Gauravpal S.
    Lodhi, Fahad K.
    Tummala, Lakshmi S.
    Singh, Steven N.
    Morgan, Charity J.
    Allman, Richard M.
    Fonarow, Gregg C.
    Ahmed, Ali
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (01): : 84 - 94
  • [25] Role of Liraglutide Use in Patients With Heart Failure
    Allam, Sanjana
    Sartaj, Sahil
    Moquim, Hiba
    Husnain, Muhammad Ammar
    Bustos, Daniel
    Lakkimsetti, Mohit
    Randhawa, Avneet K.
    Gupta, Ishita
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [26] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial
    Branch, Kelley
    Dagenais, G.
    Avezum, A.
    Basile, J.
    Conget, I.
    Cushman, W. C.
    Jansky, P.
    Lakshmanan, M.
    Lanas, F.
    Leitner, L. A.
    Pais, P.
    Pogosova, N.
    Raubenheimer, P. J.
    Gerstein, H.
    Probstfield, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 158 - 159
  • [27] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
    Branch, Kelley R. H.
    Dagenais, Gilles R.
    Avezum, Alvaro
    Basile, Jan
    Conget, Ignacio
    Cushman, William C.
    Jansky, Petr
    Lakshmanan, Mark
    Lanas, Fernando
    Leiter, Lawrence A.
    Pais, Prem
    Pogosova, Nana
    Raubenheimer, Peter J.
    Ryden, Lars
    Shaw, Jonathan E.
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    Bethel, M. Angelyn
    Gerstein, Hertzel C.
    Chinthanie, Ramasundarahettige
    Probstfield, Jeffrey L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1805 - 1812
  • [28] Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial
    Nauck, Michael A.
    Tornoe, Karen
    Rasmussen, Soren
    Treppendahl, Marianne Bach
    Marso, Steven P.
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (05): : 465 - 468
  • [29] Mediation effect analysis of lipoprotein levels on BMI and cardiovascular outcomes in patients with heart failure
    Wang, Yi
    Liu, Xiaoli
    Wu, Baochuan
    Tan, Xi
    Chen, Lin
    Chu, Heyu
    Zhou, Zeyu
    Bao, Xue
    Xu, Biao
    Gu, Rong
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [30] Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure
    James, Stefan
    Storey, Robert F.
    Oldgren, Jonas
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (02) : 91 - 92
12345